Xarelto is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Rivaroxaban.
| Product ID | 50090-4468_8ca77452-ec4d-49c5-b331-e85d586d3f81 |
| NDC | 50090-4468 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Xarelto |
| Generic Name | Rivaroxaban |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-11-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202439 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | RIVAROXABAN |
| Active Ingredient Strength | 20 mg/1 |
| Pharm Classes | Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-08-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202439 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-08-16 |
| Ingredient | Strength |
|---|---|
| RIVAROXABAN | 20 mg/1 |
| SPL SET ID: | e76bf2cf-a8b8-4471-a8ce-57c918b11a48 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-3625 | Xarelto | rivaroxaban |
| 50090-3639 | Xarelto | rivaroxaban |
| 50090-4468 | Xarelto | rivaroxaban |
| 50090-4469 | Xarelto | rivaroxaban |
| 50458-575 | Xarelto | rivaroxaban |
| 50458-577 | XARELTO | rivaroxaban |
| 50458-578 | Xarelto | rivaroxaban |
| 50458-579 | Xarelto | rivaroxaban |
| 50458-580 | Xarelto | Xarelto |
| 50458-584 | XARELTO | XARELTO |
| 55154-1423 | Xarelto | Xarelto |
| 55154-1424 | Xarelto | Xarelto |
| 55154-1422 | Xarelto | Xarelto |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XARELTO 78152154 2804753 Live/Registered |
Bayer Aktiengesellschaft 2002-08-08 |
![]() XARELTO 77752463 4105934 Live/Registered |
Bayer Aktiengesellschaft 2009-06-04 |